Clinical Trial Update: Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix

View source ↗

Summary

This clinical trial update indicates evaluation of Cadonilimab (AK104) in combination with chemotherapy for recurrent or metastatic small cell neuroendocrine ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Small Cell Neuroendocrine Carcinoma of the Cervix

Drugs mentioned

• Cadonilimab (AK104) (Cadonilimab)

Snippet

Sponsor: Ding Ma | Conditions: Cervix Cancer, Cadonilimab | Status: ENROLLING_BY_INVITATION